The WHO’s actions during the COVID-19 scandal, driven by corporate interests, have led to an unprecedented assault on individual liberties and societal well-being. Individualized treatment was ditched for a one-size-fits all set of public health mandates that exacerbated human suffering. However, merely ending a relationship with WHO does not do anyone justice. A sovereign United States must go to war with the World Health Organization and fight back against an insidious global health industry and biosecurity state that thrives on power, profit and human exploitation.

Dismantling the WHO is just the beginning; we must confront the biosecurity state in domestic healthcare systems

While disentangling from the WHO may feel like a victory, it is a hollow one unless it is part of a broader overhaul of the entire global public health infrastructure that thrives on hysteria, fraud and unlawful mandates. The WHO is but a cog in a machine that values corporate profits and political control over the health and dignity of ordinary people. It is a tool of biosecurity agendas and profit-driven policies. Simply leaving the WHO will not end this toxic system. This toxic system of human exploitation is embedded into Western healthcare. We need to break away from predatory vaccine experimentation and infectious disease fearmongering, and find an exit strategy from the entire corrupt public health industry.

In 2020, the WHO didn’t just fail the world — it became an active participant facilitating medical fraud, medical error and wrongful death. At the behest of wealthy sponsors and political elites, the organization oversaw policies that disproportionately affected the most vulnerable populations. The behemoth pushed for lockdowns that decimated economies, exacerbated poverty and pushed millions more into food insecurity. The WHO’s reckless actions forced children out of school, denied medical care to those with non-COVID-related ailments and deepened the debt crises of developing nations. Perhaps most egregiously, the organization facilitated an unconscionable transfer of wealth from the most disadvantaged to the pharmaceutical and corporate elites.

This wasn’t an unfortunate mistake — it was a calculated, intentional response to a manufactured crisis. Instead of focusing on protecting the most vulnerable, the WHO facilitated a global power grab, censoring dissent and offering unprecedented privileges to its corporate sponsors. Fostering a climate of fear and control, the WHO set the stage for future exploitation. The result? A generation of young people with stolen opportunities, impoverished nations saddled with insurmountable debt, billions of dollars in profit funneled to pharmaceutical giants and a holocaust ignored.

The WHO’s failure isn’t just a case of poor leadership or bad decisions — it’s a reflection of deep-rooted structural corruption. The organization’s original mission, established in 1946, was to ensure health equity and protect the world’s most vulnerable. But over time, it has become a grotesque shadow of that ideal. Its executives, insulated by lavish salaries and funded by the very corporations it claims to regulate, are increasingly detached from the people they were supposed to serve. This corruption is not incidental — it is intrinsic to the WHO’s very existence.

Davos elite will continue to threaten human freedom and health, while pretending to keep people safe

It is a tragic farce to watch WHO leaders attend elite summits in Davos while millions around the world suffer from the totalitarian policies they impose. These elites are not working for the global population — they are working for the interests of multinational corporations, international finance and the political elites who profit from a system of global control.

Take, for example, the WHO’s recent push to amend the International Health Regulations (IHR) under the guise of pandemic preparedness. These amendments, championed by corporate interests and political elites, would give the WHO even more sweeping powers to dictate national health policies during future crises. The WHO, once a facilitator of global health equity, has become an instrument for a biosecurity agenda that prioritizes global control and private profits over the health and freedom of individuals.

The WHO’s hand is forced by the pharmaceutical industry and the wealthy figures who look to capitalize from vaccine investments. The more money these companies pump into the organization, the more influence they wield over its policies. And the results are devastating. The WHO’s advisory guidelines on things like abortion, gender identity, vaccine skepticism and climate change reflect this unholy alliance. Its push for universal abortion access up until birth, no questions asked, and its endorsement of extreme gender ideology, show a stunning disregard for biological truth and basic human dignity.

The WHO is merely one part of a much larger, systemic problem. The global health industry, in which the WHO plays a pivotal role, is increasingly dominated by a commodity-based approach that uses healthcare as a weapon. Market exclusivity and other profit motives restrict access to healthcare. A corrupt insurance industry eliminates alternative, holistic and individualized approaches to healthcare and stops the progression of healing modalities from being accepted. From Big Pharma to the private donors funding international health initiatives, this industry is driven by the bottom line — whether that means selling dangerous vaccines, controlling supply chains or pushing austerity measures on poor nations. To reform healthcare and restore trust in medical professionals, WHO must be dismantled and its sordid influences must be removed from every healthcare systems.

Sources include:

• Expose-News.com
• NaturalNews.com
• Open.who.int
• Brownstone.org

WHO’s approval of Bavarian Nordic’s vaccine will help governments and international agencies such as the Gavi, the Vaccine Alliance, and UNICEF, buy it, MedicalXpress reported.

The MVA-BN vaccine — short for “Modified Vaccinia Ankara-Bavarian Nordic” — is a smallpox/mpox vaccine. It is sold in the U.S. under the name Jynneos.

WHO Assistant Director-General Yukiko Nakatani said, “The decision can also help national regulatory authorities to fast-track approvals, ultimately increasing access to quality-assured mpox vaccine products.”

Children’s Health Defense (CHD) Chief Scientific Officer Brian Hooker called the WHO’s approval of the shot for infants and children in Africa “a train wreck in the making.”

Hooker told The Defender:

“The safety profile is abysmal in adults (up to 2.1% serious cardiac events in clinical trials) and the vaccine has not been adequately tested for efficacy or safety in pediatric populations.

“In other words, the WHO has no idea whether it will work nor do they know how much damage it will do. The WHO has again abandoned good public health principles and waved their magic vaccine wand on the mpox outbreak.”

Dr. David Bell, a public health physician and biotech consultant, also criticized the WHO for overly focusing on mpox vaccines and neglecting to address broader public health issues in Africa.

“So far this year, about 40,000 children have died from malaria in the DRC [Democratic Republic of Congo] alone, and similar numbers of people from malnutrition, tuberculosis and HIV/AIDs,” Bell said.

Although these numbers “obviously dwarf” the number of mpox deaths, the WHO is allocating fewer resources to addressing them.

Bell — who formerly served as a medical officer and scientist at the WHO — explained what he sees occurring:

“We have become much better at detecting much rarer diseases such as mpox, and addressing these is certainly more lucrative for the growing industry feeding off the WHO’s misinformation regarding rapidly rising pandemic risk.

“However, it is clear that the people of DRC and Africa in general would benefit far more if WHO returned to impactful public health. There has been a move over recent years to a concentration on addressing the symptoms of diseases of poverty (which mpox is) with Western-developed commodities, rather than dealing with underlying causes.

“This signals a return to colonialist-era approaches rather than evidence-based public health. It presumably reflects the way WHO is now funded, with increasing control from the private sector and a few large Western nations with large Pharma industries.”

No clinical trials on kids

In its press release, the WHO said the MVA-BN vaccine can be administered to adults over 18 as a two-dose injection four weeks apart but can also be given as a single dose “in supply-constrained outbreak situations.”

“While MVA-BN is currently not licensed for persons under 18 years of age,” it said, “this vaccine may be used ‘off-label’ in infants, children and adolescents, and in pregnant and immunocompromised people.”

The WHO called for more data on the vaccine’s safety and efficacy in these situations.

The WHO Strategic Advisory Group of Experts on Immunization — which reviewed all available evidence and recommended the use of MVA-BN vaccine — noted in its Weekly Epidemiological Record report that “MVA-BN has not been specifically studied in clinical trials in children.”

However, they said:

“The same non-replicating MVA viral vector is used as a platform for other vaccines that include MVA-filo (Mvabea) against Ebola virus disease (EVD).

“The EVD vaccine is approved by the EU for adults and children aged 1 year and older. Data from 5 published studies on MVA-BN as a viral vector platform for the prevention of EVD, with a total population of 52 229 children, support the favourable safety profile of the product.”

The authors of a new study — published Sept. 11 in The BMJ — presented results on MVA-BN’s effectiveness in adult males but said nothing about children or pregnant women.

In 2023, researchers funded by the UK Health Security Agency looked at the health outcomes of 87 children who received a single dose of MVA-BN.

They reported that the vaccine was “well tolerated” but that larger studies needed to be done to fully assess the shot’s safety and efficacy in kids.

The Defender asked Bavarian Nordic for information about its mpox vaccine in pediatric populations but did not receive a response by the deadline.

The WHO’s process for granting a drug “prequalification” approval for “emergency use listing” requires drugmakers to “commit to continue generating missing information to fulfill prequalification requirements.”

“Once this information becomes available,” the WHO said, “a PQ [prequalification] application should be submitted to complete the full process to achieve  recommendation for international procurement in both emergency and non-emergency settings.”

It is unclear how much pediatric safety and efficacy data Bavarian Nordic has collected so far and what it showed.

Mpox vaccine approved for U.S. kids and teens since 2022

The U.S. Food and Drug Administration (FDA) in 2022 granted emergency use authorization for the vaccine for “in individuals less than 18 years of age determined to be at high risk for monkeypox infection.”

Jynneos has been licensed for use in U.S. adults since 2019.

The Centers for Disease Prevention and Control (CDC)’s mpox vaccination website states that while teens and children at risk for mpox can receive Jynneos, it is not recommended for babies under 6 months.

The CDC also says Jynneos can be given to pregnant or breastfeeding women.

Although it remains unknown if Jynneos may pose risks to a developing fetus if taken during pregnancy, animal studies haven’t shown any harm to developing fetuses when the vaccine was given to pregnant animals, the agency said.